Thelansis

Basal cell carcinoma(also called basal cell skin cancer) is generally defined as a locally invasive, slowly spreading tumor that rarely metastasizes, arising in the epidermis or hair follicles. Etiology- The main etiological factor responsible for BCC is the chronic UV exposure at the expense mostly of UVB rays with length 290-320 mm. This results in activating of proto-oncogenes and the inactivation of tumor-suppressive genes in the keratinocytes. Epidemiology- Basal cell carcinoma is quite common, and the number of reported cases in the U.S. has steadily increased. More than 4 million Americans are diagnosed with BCC each year. The incidence of BCC is about 2000 cases per 100 000 population. The competitive landscape of Basal Cell Carcinoma (BCC) includes country-specific approved and pipeline therapies. Any asset/product-specific designation or review and Accelerated Approval are tracked and supplemented with analyst commentary. KOLs insights of Basal Cell Carcinoma (BCC) across 8 ...